InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,544.59
(
-0.78%
)
US TECH 100
19,179.60
(
0.00%
)
Dow Jones
40,665.02
(
-1.29%
)
Brent Oil
83.80
(
-0.34%
)
Bitcoin
63,981.99
(
0.02%
)
Post# of 252638
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120079
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 107944

Tuesday, 11/02/2010 10:31:31 PM

Tuesday, November 02, 2010 10:31:31 PM

Post# of 252638

Is the Street questioning Teva so relentlessly because they see their dominance being challenged, because of Copaxone or because of Momenta?

Because of the threat to Copaxone in the US market, which accounts for 25-30% of Teva’s overall corporate profits.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up